Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α
The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells.
Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice.
Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies.
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
Prevention and treatment of MS: studying the effects of vitamin D.
Potassium-Retaining Diuretics: Amiloride
Food and Drug Administration Approval Letter for Alemtuzumab
Saccadic intrusions: review and update.
Considering the influence of stimulation parameters on the effect of conventional and high-definition transcranial direct current stimulation.
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.
Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.
Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.
Early relapses, onset of progression, and late outcome in multiple sclerosis.
JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level.
Mitochondrial approaches for neuroprotection.
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases.
BRIEF-AB Science says DSMB recommends continuation of phase 3 masitinib study
Molecular properties of epithelial, amiloride-blockable Na+ channels.
Substance Name: Amiloride
Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial.
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.
Monoclonal antibodies conjugated with superparamagnetic iron oxide particles allow magnetic resonance imaging detection of lymphocytes in the mouse brain.
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.

Pages